Dopamine transporter SPECT in patients with mitochondrial disorders
- PMID: 15608010
- PMCID: PMC1739307
- DOI: 10.1136/jnnp.2004.040220
Dopamine transporter SPECT in patients with mitochondrial disorders
Abstract
Background: Mitochondrial disorders may affect basal ganglia function. In addition, decreased activity of complex I of the mitochondrial electron transport chain has been linked to the pathogenesis of dopaminergic cell loss in Parkinson's disease. Objective : To investigate the dopaminergic system in patients with known mitochondrial disorders and complex I deficiency.
Methods: Dopamine transporter density was studied in 10 female patients with mitochondrial complex I deficiency by (123)I-FP-CIT (N-beta-fluoropropyl-2beta-carbomethyl-3beta-(4-iodophenyl)-nortropane) SPECT.
Results: No differences in (123)I-FP-CIT striatal binding ratios were observed and no correlation of the degree of complex I deficiency and striatal binding ratios could be detected.
Conclusions: These data argue against the possibility that mitochondrial complex I deficiency by itself is sufficient to elicit dopaminergic cell loss.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources